Key Points
Initiates with a buy as companys returns profile to see steady expansion Offline shift to drive a steady scale-up in its business, push revenue growth Management looking to keep business asset light..
Foray into new markets through hospital buyouts to boost revenues from FY25 Company to expand bed capacity by 94% over FY24-27 most aggressive bed expansion plan among peers Despite bed addition plan, fi nancials unlikely to be under any stress because of cash on balance sheet..
Transitioning into a lifestyle brand from being an innerwear manufacturer Premium valuation versus others reflects superior growth outlook Expect company to cross Rs 2,000 crore revenue in FY26 versus Rs 1,393 crore posted in FY23.
You might be interested in
Analysts bet on DCB Bank, Manappuram Finance & Global Health
29, Sep, 23ET looks at some of the stock recommendations by analysts of late. These stocks are expected to return between 16% and 23% as per analysts price targets.
Trent Q1 results: Profit jumps 44% at ₹148.27 crore
09, Aug, 23Standalone revenue from operations grew 53.4% from ₹1,652.86 crore reported in they ago period to ₹2,536.43 crore, the company said
Dabur Q2 Results: PAT rises 5% YoY to Rs 515 crore; dividend declared at Rs 2.75/share
02, Nov, 23Revenue from operations increased 7% year-on-year to Rs 3,204 crore in the reporting period. The Board has also approved an interim dividend of Rs 2.75 per equity share for the financial year 2023-24.
RIL Q1 Results: Profit slumps 11% YoY to Rs 16,011 crore, misses estimates
21, Jul, 23The board has recommended dividend payout of Rs 9 a share, subject to approval of the shareholders.
Learn With ETMarkets: Understanding CAGR, XIRR and Absolute Return!
11, Mar, 23In order to make intelligent investment, it is essential to understand which type of return is being discussed. This will help you put money in the right place to create wealth.
Analysts' top small-cap picks for 2024 that can give returns up to 42%
28, Dec, 23These stocks are expected to return between 21% and 42% as per analysts price targets.
ITC Q1 Preview: PAT may rise 15% YoY despite muted sales; cigarette ops show steady growth
13, Aug, 23The higher growth in the profit despite a muted topline is primarily due to ITCs higher dependence on the cigarette business. Despite a scale-up in the FMCG business, cigarettes constitute close to 70% of ITCs profit and about 45% of its revenue.
Q4 results today: What UltraTech, SBI Card, Star Health and IndiaMart numbers might look like
28, Apr, 23Nifty companies UltraTech, SBI Cards, Star Health and IndiaMart will release their Q4 earnings today. Motilal Oswal predicts UltraTech Cement's sales volumes growth by 14% YoY and 22% QoQ. SBI Card's revenue growth is expected at 15% YoY, while NII growth is seen at 3%. Kotak Institutional Equities estimates Star Health to report a net profit of Rs 81 crore this quarter. Lastly, IndiaMart is expected to report robust revenue growth, while the bonus issue will be considered with the Q4 results.
Piramal Pharma revenue up 11% to ₹1,911 crore in Q2
28, Oct, 23Consolidated profit after tax came in at ₹5 crore in the quarter, as against a loss in the corresponding quarter last year
Tata Consumer Q2 Results: Profit rises 3% YoY to Rs 338 crore; revenue up 11%
31, Oct, 23Revenue from operations during the reporting second quarter jumped 11% year-on-year (YoY) to Rs 3,734 crore. The same was at Rs 3,363 crore in the last year quarter. The revenue growth was driven by an underlying growth of 11% in the India business, 8% in the International business, and 3% in the non-branded business.